Cargando…
Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
BACKGROUND: Esophageal cancer remains one of the hardest cancers to treat with rising incidence rates, low overall survival and high levels of treatment resistance. The lack of clinically available biomarkers hinder diagnosis and treatment stratification. While large scale sequencing approaches have...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136712/ https://www.ncbi.nlm.nih.gov/pubmed/30212533 http://dx.doi.org/10.1371/journal.pone.0203173 |